Background: The pathogenesis of depression may involve low-grade inflammation and endothelial dysfunction. We aimed to evaluate the independent associations of inflammation and endothelial dysfunction with depressive symptoms and depressive disorder, and the role of lifestyle factors in this association. Methods: In The Maastricht Study, a population-based cohort study (n = 852, 55% men, m = 59.8 ± 8.5 years), depressive symptoms were assessed with the Patient Health Questionnaire-9 and (major and minor) depressive disorder with the Mini-International Neuropsychiatric Interview. Plasma biomarkers of inflammation (hsCRP, SAA, sICAM-1, IL-6, IL-8, TNF-a) and endothelial dysfunction (sVCAM-1, sICAM-1, sE-selectin, vWF) were measured with sandwich immunoassays and combined into two standardized sum scores. Results: Biomarkers of inflammation (hsCRP, TNF-a, SAA, sICAM-1) and endothelial dysfunction (sICAM-1, sE-Selectin) were univariately associated with depressive symptoms and depressive disorder. The sum scores of inflammation and endothelial dysfunction were associated with depressive disorder after adjustment for age, sex, type 2 diabetes, kidney function and prior cardiovascular disease (OR 1.54, p = 0.001 and 1.40, p = 0.006). Both sum scores remained significantly associated with depressive disorder after additional adjustment for lifestyle factors smoking, alcohol consumption and body mass index. The sum score of inflammation was also independently associated with depressive symptoms, while the sum score of endothelial dysfunction was not. Conclusions: Inflammation and endothelial dysfunction are both associated with depressive disorder, independent of lifestyle factors. Our results might suggest that inflammation and endothelial dysfunction are involved in depression.
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Introduction
Depression is a complex disorder with a highly variable course, an inconsistent response to treatment, and no established mechanism. Its development is probably characterized by the interaction between biological, genetic and environmental factors (Oladeji and Gureje, 2013) . Apart from the detrimental impact of depression on the quality of life of individuals affected with the disorder and their family members, depression is also related to high societal costs as a consequence of diminished work productivity and increased use of health care (Greenberg et al., 2015) . According to the World Health Organization (WHO), depression is the leading cause of disability worldwide, and is a major contributor to the overall global burden of disease as measured by Disability Adjusted Lived Years (WHO, 2015) , therefore making the identification of its etiology a research priority.
